FDA Approved: * March 26, 2015
Pharm Company: * PAR PHARM INC
Category: Parkinsons

Tolcapone, sold under the brand name Tasmar, is a medication used to treat Parkinson's disease (PD). It is a selective, potent and reversible nitrocatechol-type inhibitor of the enzyme catechol-O-methyltransferase (COMT).[1] It has demonstrated significant liver toxicity, which has led to suspension of marketing authorisations in a number of countries. In comparison with entacapone, another nitrocatechol COMT inhibitor, tolcapone has a longer half life (2.9 hours vs. 0.8 hour... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Tolcapone 100 1/1 Oral Tablet, Coated
NDC: 49884-254
Par Pharmaceutical Companies, Inc.
Tolcapone 100 mg Oral Tablet
NDC: 50742-193
Ingenus Pharmaceuticals, LLC
Tolcapone 100 mg Oral Tablet, Film Coated
NDC: 68682-938
Oceanside Pharmaceuticals

Related Brands

Drugs with the same active ingredients